US Patent Issued to Gan & Lee Pharmaceuticals on Aug. 11 for "Long-acting GLP-1 compound" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,731, issued on Aug. 11, was assigned to Gan & Lee Pharmaceuticals Co. Ltd. (Beijing).

"Long-acting GLP-1 compound" was invented by Zhongru Gan (Beijing), Wei Chen (Beijing), Yining Zhang (Beijing), Fangkai Xue (Beijing), Lingyu Cai (Beijing), Jianghong Niu (Beijing) and Bin Mu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel GLP-1 derivative, compared with GLP-1 derivatives such as liraglutide and semaglutide which are on the market, has comparable or better effect, potency or efficacy, longer or comparable duration of action in vivo or half-life in vivo, has better or comparable GLP-1 receptor binding affinity and has better or compa...